Stemagen

Stemagen is a corporation headed by Dr. Samuel Wood, notable for cloning adult skin cells.[1][2][3] On January, 2008, Dr. Andrew French, Stemagen's chief scientific officer and Wood in California, announced that they successfully created the first 5 mature human embryos using DNA from adult skin cells, aiming to provide a less-controversial source of viable embryonic stem cells.[4] Dr. Wood and a colleague donated skin cells, and DNA from those cells was transferred to human eggs. It is not clear if the embryos produced would have been capable of further development, but Dr. Wood stated that if that were possible, using the technology for reproductive cloning would be both unethical and illegal. The 5 cloned embryos, created in Stemagen Corporation lab, in La Jolla, were later destroyed to confirm the nuclear transfer process.[5]

Dr. French, lead author, and five other researchers published their findings in the online research journal Stem Cells, in an article entitled Development of human cloned blastocysts following somatic cell nuclear transfer (SCNT) with adult fibroblasts.[4][6]

See also

References

  1. ↑ Macrae, Fiona Ethical storm as scientist becomes first man to clone HIMSELF Daily Mail
  2. ↑ Ricks, Delthia Scientists make human embryo clone newsday.com
  3. ↑ Prinewswire Stemagen First to Create Cloned Human Embryos From Adult Cells Jan. 17, 2008 Genetic Engineering & Biotechnology News
  4. 1 2 Somers, Terri Biotech Stemagen fused skin and egg to clone embryo The San Diego Union-Tribune, January 18, 2008
  5. ↑ Weiss, Rick Mature Human Embryos Created From Adult Skin Cells Washingtonpost.com
  6. ↑ French, Andrew J., Cathrine A. Adams et al. Development of human cloned blastocysts following somatic cell nuclear transfer (SCNT) with adult fibroblasts Stem Cells published by AlphaMed Press 2008 Feb;26(2):485-93. Epub 2008 January 17, 2008. doi:10.1634/stemcells.2007-0252


This article is issued from Wikipedia - version of the Wednesday, April 11, 2012. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.